- Active not recruitingPHASE1, PHASE2
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
This study looks at a new treatment called AUTO1 for adults with a type of blood cancer called B-cell acute lymphoblastic leukaemia (ALL) that has come back or not responded to previous treatments. It aims to see if AUTO1 is safe and effective.
For: Relapsed or Refractory B Cell Acute Lymphoblastic LeukemiaUnited States · Spain · United Kingdom - RecruitingPHASE1
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
This study looks at a new type of cell therapy called CAR T-cell therapy (AUTO1) for children and teenagers with types of blood cancer (leukaemia or lymphoma) that haven't responded to other treatments. It checks how safe and effective it is.
For: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia · Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States · Spain · United Kingdom